Index Performance
+0.84%
MDBH
+7.28%
SPY
+5.32%
DIA
Overview
Description
Biotech companies between $30 million and $400 million market capitalization
- TickerMDBH
- Inception Date12/07/2023
- WeightingEqual
- # of holdings115
What's inside?
Holdings
All holdings as of July 26, 2024
CSV download
| Sangamo Therapeutics, Inc. (SGMO) | 1.56% | $139.45M | -99.70% | -425.16% | 5.14 |
| uniQure NV (QURE) | 1.46% | $416.07M | 59.34% | -39.72% | 12.55 |
| Seres Therapeutics, Inc. (MCRB) | 1.37% | $205.97M | N/A | N/A | 1.70 |
| Adaptimmune Therapeutics Plc (ADAP) | 1.25% | $332.23M | -88.19% | 50.16% | 14.30 |
| Design Therapeutics, Inc. (DSGN) | 1.25% | $276.83M | N/A | N/A | N/A |
| Humacyte, Inc. (HUMA) | 1.23% | $970.54M | N/A | N/A | N/A |
| C4 Therapeutics, Inc. (CCCC) | 1.23% | $443.11M | -19.15% | 33.30% | 18.50 |
| Prelude Therapeutics, Inc. (PRLD) | 1.22% | $252.06M | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE) | 1.16% | $614.69M | -96.74% | -150.44% | 71.11 |
| Neoleukin Therapeutics, Inc. (NLTX) | 1.16% | $576.56M | N/A | N/A | N/A |
| Solid Biosciences, Inc. (SLDB) | 1.15% | $347.33M | N/A | N/A | N/A |
| Poseida Therapeutics, Inc. (PSTX) | 1.14% | $350.02M | 172.09% | 95.10% | 2.33 |
| Athira Pharma, Inc. (ATHA) | 1.14% | $127.25M | N/A | N/A | N/A |
| XBiotech, Inc. (XBIT) | 1.13% | $213.81M | N/A | N/A | N/A |
| Avid Bioservices, Inc. (CDMO) | 1.09% | $656.16M | -6.27% | 5.23% | 4.66 |
| CARA Therapeutics, Inc. (CARA) | 1.08% | $19.96M | -65.37% | 68.99% | 1.50 |
| Immunome, Inc. (IMNM) | 1.07% | $961.30M | -56.47% | 74.44% | 76.01 |
| Spyre Therapeutics, Inc. (AGLE) | 1.05% | $1.53B | -100.00% | N/A | 1,945.66 |
| Graphite Bio, Inc. (GRPH) | 1.05% | $611.24M | N/A | N/A | N/A |
| Compass Pathways Plc (CMPS) | 1.03% | $509.84M | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE) | 1.03% | $285.57M | N/A | -78.29% | 259.77 |
| Black Diamond Therapeutics, Inc. (BDTX) | 1.03% | $350.45M | N/A | N/A | N/A |
| Nkarta, Inc. (NKTX) | 1.03% | $486.93M | N/A | N/A | N/A |
| Foghorn Therapeutics, Inc. (FHTX) | 1.02% | $360.74M | -4.88% | 83.47% | 3.57 |
| Cognition Therapeutics, Inc. (CGTX) | 1.00% | $84.12M | N/A | N/A | N/A |
| Xeris Biopharma Holdings, Inc. (XERS) | 0.99% | $378.79M | 22.42% | 78.64% | 2.87 |
| Kodiak Sciences, Inc. (KOD) | 0.99% | $169.16M | N/A | N/A | N/A |
| Nuvation Bio, Inc. (NUVB) | 0.98% | $913.90M | N/A | N/A | N/A |
| Seer, Inc. (California) (SEER) | 0.98% | $125.44M | -24.35% | -4.34% | -10.26 |
| Replimune Group, Inc. (REPL) | 0.98% | $716.01M | N/A | N/A | N/A |
| Instil Bio, Inc. (TIL) | 0.97% | $82.40M | N/A | N/A | N/A |
| Anixa Biosciences, Inc. (ANIX) | 0.97% | $92.50M | -100.00% | N/A | N/A |
| Trevi Therapeutics, Inc. (TRVI) | 0.97% | $223.28M | N/A | N/A | N/A |
| Vigil Neuroscience, Inc. (VIGL) | 0.96% | $172.51M | N/A | N/A | N/A |
| Aldeyra Therapeutics, Inc. (ALDX) | 0.96% | $243.01M | N/A | N/A | N/A |
| Nautilus Biotechnology, Inc. (NAUT) | 0.96% | $360.76M | N/A | N/A | N/A |
| OncoCyte Corp. (OCX) | 0.95% | $44.91M | -40.74% | -190.34% | 19.76 |
| Ventyx Biosciences, Inc. (VTYX) | 0.94% | $204.45M | N/A | N/A | N/A |
| Larimar Therapeutics, Inc. (LRMR) | 0.94% | $601.02M | N/A | N/A | N/A |
| iTeos Therapeutics, Inc. (ITOS) | 0.93% | $603.61M | -100.00% | N/A | N/A |
| INmune Bio, Inc. (INMB) | 0.93% | $167.56M | -63.16% | N/A | 1,479.00 |
| Carisma Therapeutics, Inc. (SESN) | 0.93% | $44.87M | 4.75% | 50.16% | 2.91 |
| MeiraGTx Holdings Plc (MGTX) | 0.92% | $327.32M | -79.09% | -369.87% | 31.46 |
| Voyager Therapeutics, Inc. (VYGR) | 0.92% | $499.88M | -87.03% | 93.87% | 1.51 |
| Leap Therapeutics, Inc. (LPTX) | 0.92% | $83.03M | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (CRTX) | 0.90% | $33.71M | N/A | N/A | N/A |
| TScan Therapeutics, Inc. (TCRX) | 0.90% | $348.85M | -91.68% | -121.55% | 18.59 |
| Syros Pharmaceuticals, Inc. (SYRS) | 0.89% | $161.44M | -100.00% | N/A | 23.19 |
| Stoke Therapeutics, Inc. (STOK) | 0.89% | $758.88M | -18.17% | 73.60% | 57.63 |
| LAVA Therapeutics NV (LVTX) | 0.89% | $55.48M | 471.24% | 96.47% | 0.06 |
| VistaGen Therapeutics, Inc. (VTGN) | 0.88% | $98.48M | N/A | 46.62% | -13.96 |
| Galectin Therapeutics, Inc. (GALT) | 0.88% | $158.48M | N/A | N/A | N/A |
| Precigen, Inc. (PGEN) | 0.88% | $419.02M | -42.46% | -76.10% | 59.44 |
| PepGen Inc. (PEPG) | 0.87% | $584.16M | N/A | N/A | N/A |
| IO Biotech, Inc. (IOBT) | 0.87% | $88.28M | N/A | N/A | N/A |
| Elutia, Inc. (AZYO) | 0.87% | $87.04M | -48.70% | 42.47% | 3.40 |
| Precision BioSciences, Inc. (DTIL) | 0.86% | $70.43M | 100.27% | 91.88% | -0.66 |
| BioAtla, Inc. (BCAB) | 0.86% | $81.80M | N/A | N/A | N/A |
| Spruce Biosciences, Inc. (SPRB) | 0.86% | $22.42M | 1.93% | 99.25% | -4.41 |
| Invivyd, Inc. (ADGI) | 0.85% | $153.92M | N/A | N/A | N/A |
| AlloVir, Inc. (ALVR) | 0.85% | $86.93M | N/A | N/A | N/A |
| Altimmune, Inc. (ALT) | 0.85% | $474.34M | -76.19% | -2,040.00% | 1,315.24 |
| Spero Therapeutics, Inc. (SPRO) | 0.84% | $76.39M | 468.11% | N/A | 0.15 |
| Eliem Therapeutics, Inc. (ELYM) | 0.84% | $594.39M | N/A | N/A | N/A |
| Akoya Biosciences, Inc. (AKYA) | 0.84% | $120.50M | -14.29% | 45.66% | 2.72 |
| 23andMe Holding Co. (ME) | 0.83% | $152.13M | -26.66% | 31.82% | 0.51 |
| Kezar Life Sciences, Inc. (KZR) | 0.83% | $47.93M | N/A | N/A | -13.70 |
| AVROBIO, Inc. (AVRO) | 0.83% | $65.98M | N/A | N/A | N/A |
| CorMedix, Inc. (CRMD) | 0.83% | $258.86M | N/A | N/A | N/A |
| Enzo Biochem, Inc. (ENZ) | 0.82% | $58.66M | -50.20% | 46.53% | -0.05 |
| Shattuck Labs, Inc. (STTK) | 0.81% | $210.65M | 1,856.14% | 12.65% | 125.76 |
| BioXcel Therapeutics, Inc. (BTAI) | 0.81% | $43.91M | 182.52% | 72.85% | 65.63 |
| Passage Bio, Inc. (PASG) | 0.81% | $54.24M | N/A | N/A | N/A |
| BioVie, Inc. (BIVI) | 0.80% | $27.07M | N/A | N/A | N/A |
| Enlivex Therapeutics Ltd. (ENLV) | 0.80% | $29.01M | N/A | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI) | 0.80% | $214.07M | N/A | N/A | N/A |
| InflaRx NV (IFRX) | 0.80% | $90.09M | N/A | -511.93% | 11.55 |
| Ikena Oncology, Inc. (IKNA) | 0.79% | $81.07M | -100.00% | N/A | -20.55 |
| Vaxart, Inc. (VXRT) | 0.79% | $154.40M | 223.11% | 49.56% | 23.24 |
| SAB Biotherapeutics, Inc. (SABS) | 0.79% | $26.40M | 62.55% | -110.12% | 1.29 |
| Mersana Therapeutics, Inc. (MRSN) | 0.79% | $242.28M | 18.50% | 95.42% | 10.29 |
| MiNK Therapeutics, Inc. (INKT) | 0.79% | $32.30M | N/A | N/A | N/A |
| ProKidney Corp. (DNAC) | 0.79% | $276.95M | N/A | N/A | N/A |
| Champions Oncology, Inc. (CSBR) | 0.79% | $65.39M | -6.90% | 41.38% | 1.41 |
| HOOKIPA Pharma, Inc. (HOOK) | 0.77% | $61.02M | 1,052.36% | 98.25% | 0.06 |
| Heron Therapeutics, Inc. (HRTX) | 0.76% | $467.02M | 17.07% | 75.64% | 3.99 |
| Verastem, Inc. (VSTM) | 0.75% | $75.22M | N/A | N/A | N/A |
| Aadi Bioscience, Inc. (AADI) | 0.75% | $39.53M | -8.76% | 87.82% | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | 0.75% | $320.72M | N/A | N/A | N/A |
| Reneo Pharmaceuticals, Inc. (RPHM) | 0.74% | $49.80M | N/A | N/A | N/A |
| Gritstone bio, Inc. (GRTS) | 0.73% | $71.31M | -90.96% | -3,455.10% | 429.08 |
| Aspira Women's Health, Inc. (AWH) | 0.72% | $21.41M | -7.04% | 56.39% | 4.00 |
| Compugen Ltd. (CGEN) | 0.72% | $157.57M | N/A | 17.86% | 3.69 |
| ImmuCell Corp. (ICCC) | 0.72% | $32.50M | 110.58% | 31.63% | 2.65 |
| Cyclo Therapeutics, Inc. (CYTH) | 0.71% | $32.05M | 32.83% | -313.18% | 33.20 |
| Century Therapeutics, Inc. (IPSC) | 0.70% | $201.11M | -50.29% | -277.31% | 83.83 |
| Affimed NV (AFMD) | 0.70% | $77.66M | -96.52% | N/A | 10.60 |
| X4 Pharmaceuticals, Inc. (XFOR) | 0.69% | $145.23M | N/A | N/A | N/A |
| ImmunoPrecise Antibodies Ltd. (IPA) | 0.68% | $21.95M | 19.97% | 39.99% | 3.01 |
| Coeptis Therapeutics Holdings, Inc. (BHSE) | 0.67% | $9.93M | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO) | 0.67% | $48.61M | 18.26% | 32.20% | 1.30 |
| Renovaro, Inc. (ENOB) | 0.67% | $184.38M | N/A | N/A | N/A |
| HCW Biologics Inc. (HCWB) | 0.67% | $22.73M | 2,590.14% | 32.95% | 17.66 |
| Gain Therapeutics, Inc. (GANX) | 0.65% | $18.77M | -100.00% | N/A | N/A |
| Vor Biopharma, Inc. (VOR) | 0.65% | $64.96M | N/A | N/A | N/A |
| Omega Therapeutics, Inc. (OMGA) | 0.63% | $102.04M | 357.36% | 23.05% | 54.44 |
| Taysha Gene Therapies, Inc. (TSHA) | 0.62% | $457.13M | -27.52% | 90.47% | 42.38 |
| Curis, Inc. (CRIS) | 0.62% | $35.48M | -9.19% | 77.71% | 6.60 |
| Co-Diagnostics, Inc. (CODX) | 0.61% | $35.10M | -58.01% | -123.58% | -2.13 |
| Rani Therapeutics Holdings, Inc. (RANI) | 0.57% | $83.53M | N/A | N/A | N/A |
| Nascent Biotech, Inc. (NBIO) | 0.45% | $8.61M | N/A | N/A | N/A |
| Cue Biopharma, Inc. (CUE) | 0.40% | $34.21M | 818.18% | 50.55% | 9.32 |
| Agenus, Inc. (AGEN) | 0.36% | $125.26M | 22.28% | 87.57% | 3.36 |
| Vaxxinity, Inc. (VAXX) | 0.13% | $7.61M | N/A | N/A | N/A |
| eFFECTOR Therapeutics, Inc. (EFTR) | 0.03% | $0.22M | N/A | N/A | N/A |
Market data by FactSet